<DOC>
	<DOCNO>NCT00029315</DOCNO>
	<brief_summary>This study evaluate recombinant tissue plasminogen activator ( rt-PA ) utilized patient intraventricular hemorrhage ( IVH ) . rt-PA drug show dissolve blood , may allow intraventricular catheter effective long period time .</brief_summary>
	<brief_title>Intraventricular Rt-PA Patients With Intraventricular Hemorrhage</brief_title>
	<detailed_description>IVH occur 40 percent intracerebral hemorrhage case 15 percent aneurysmal subarachnoid hemorrhage case . Evidence support strong contribution IVH morbidity mortality cerebral hemorrhage . External ventricular drainage ( EVD ) require clinical management ; however , EVD via intraventricular catheter alone fail prevent much morbidity mortality IVH . This study seek demonstrate safety efficacy intraventricular thrombolysis , use rt-PA , method remove blood alter morbidity mortality . Patients receive intraventricular injection rt-PA placebo every 12 hour . They follow prospectively daily head CT scan acute-treatment phase Days 28 32 . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Inclusion criterion : Intraventricular hemorrhage ( IVH ) confirm CT scan More 12 hour post bleed Hematoma size stable CT scan PostIVH catheter CT scan Able begin study within 24 hour bleed Exclusion criterion : Infratentorial bleed Supratentorial bleed great 30 cc Unclipped aneurysm suspect Arteriovenous malformation suspect Any severe , complicate illness ( e.g. , AIDS DNR ) Cardiovascular parameter could confound study ( e.g. , myocardial infarction , pulmonary embolus , systemic fibrinolysis ) Active internal bleeding Requirement heparin dose great 10,000 U/day Concurrent coumadin Known allergy rtPA Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>Intraventricular hemorrhage</keyword>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Intracerebral hemorrhage</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Recombinant Proteins</keyword>
	<keyword>Anticoagulants</keyword>
	<keyword>Tissue Plasminogen Activator</keyword>
	<keyword>Pharmacology</keyword>
	<keyword>Catheters , Indwelling</keyword>
	<keyword>Cerebral Ventricles</keyword>
</DOC>